DePuy Synthes (Johnson & Johnson)
About DePuy Synthes (Johnson & Johnson)
DePuy Synthes, an orthopaedics company of Johnson & Johnson, offers a comprehensive portfolio of orthopaedic and neurosurgery products and services. Their solutions are designed to help heal and restore movement for millions of patients worldwide. The company’s offerings span various specialties, including joint reconstruction, trauma, craniomaxillofacial surgery, spinal surgery, and sports medicine. DePuy Synthes emphasizes a commitment to quality and innovation, aiming to simplify patient mobility.
For physicians, DePuy Synthes provides a wide array of products and technologies for surgical fixation and orthopedic procedures. These include implants and biomaterials for reconstructing damaged or diseased joints, repairing traumatic skeletal injuries, facilitating spinal fusion, and correcting spinal deformities. The company also supports the medical community through educational grants and fellowships for physicians in training, collaborating with institutions and third-party foundations to advance orthopaedic education and patient care.
Johnson & Johnson announced in October 2025 its intent to separate its Orthopaedics business, which operates as DePuy Synthes, into a standalone public company. This strategic move aims to allow both entities to thrive with a more concentrated strategic and operational focus, with the standalone DePuy Synthes positioned to be the largest pure-play orthopedics company globally.
Focus Areas
Business Intelligence
| Key Investors | Johnson & Johnson (Acquirer) |
| Partnerships | AO Foundation |
| Acquisitions | Synthes (2012), AcroMed (1998), OrthoSpin (2021), CrossRoads Extremity Systems (2022), selective rights to Gemtrack technology from MinMaxMedical (agreement in 2026) |
| Technology | VELYS™ Digital Surgery portfolio (includes VELYS™ Hip Navigation with AI Assistance, VELYS™ Robotic-Assisted Knee Solutions, VELYS™ Spine), AI-powered image interpretation, machine learning models, cloud-native (implied by digital solutions and data-driven approach) |
| FDA Clearances | Unknown (OrthoSpin G2 System received 510(k) clearance in 2021) cleared products (estimated) |
What Physicians Need to Know
DePuy Synthes emphasizes a 'beyond the implant' approach, focusing on integrated solutions that optimize processes, provide patient-specific information, and improve overall surgical experiences. Physicians can leverage their extensive educational resources through the Johnson & Johnson Institute to enhance their skills. The company's focus on digital surgery, robotics, and personalized solutions aims to improve precision, streamline workflows, and enhance patient outcomes. Their commitment to simplifying minimally invasive surgery with differentiated technologies like the VIPER PRIMEu2122 System and CONCORDEu00ae Clear MIS Discectomy Tool can lead to reduced procedural time and improved reproducibility.
DePuy Synthes is actively integrating advanced technologies through collaborations and acquisitions. They have partnered with the AO Foundation for product and surgical innovation and with Brainlab for digital surgery technologies, pre-operative planning, visualization, navigation, and robotics in spine. Their VELYSu2122 Digital Surgery platform is designed to connect various technologies pre-, intra-, and post-operatively. Recent agreements, such as the acquisition of Gemtrack technology, highlight their push for integrated image-guided and robotic-assisted joint surgery.
What the Web Says
DePuy Synthes, a Johnson & Johnson company, is a major player in orthopedic and neurosurgical medical devices. The company is in the process of separating from Johnson & Johnson to become a standalone entity, aiming for greater agility and focus in the orthopedic market. Reviews indicate a mixed sentiment, with some employees praising the work environment, pay, and opportunities for growth, while others express concerns about work-life balance, management decisions, and the impact of the separation.
Overall: MixedStrengths
- Interesting and rewarding work, particularly in areas like data management and improving patient lives.
- Good pay and benefits for some roles, with a liveable wage for certain positions.
- Positive work environment and culture reported by some employees, with helpful colleagues.
- Opportunities for career development and advancement.
- Strong product portfolio in joint reconstruction, trauma, spine, sports medicine, and other areas.
- Innovation in products like the Velys robot for total joint replacements.
Limitations
- Challenging work-life balance, especially for trauma sales roles, with long hours and constant demand.
- Concerns about job security and potential negative impacts on employees due to the separation from Johnson & Johnson.
- Some employees, particularly contractors, report significantly lower pay.
- Criticism of management decisions, including commission reductions and forcing reps to pay for new hires.
- Perceived lack of innovation in some product areas compared to competitors.
- Union-related issues creating a tough work environment in some facilities.
Based on reviews from: Indeed, Comparably, Which Medical Device, Rannkly, Reddit, Becker's Spine Review, PMC, SPINEMarketGroup, OpenLM, The Company That Invented Orthopedics Is Betting It Can Reinvent Itself, Johnson & Johnson MedTech
Last updated: 2026-06-19
Videos
News, demos, and interviews about DePuy Synthes (Johnson & Johnson).
Videos load interactively. If none appear, search YouTube for DePuy Synthes (Johnson & Johnson) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]